Addiction Research Centres and the Nurturing of Creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

ABSTRACT The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug‐related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a com...

Full description

Saved in:
Bibliographic Details
Published in:Addiction (Abingdon, England) Vol. 107; no. 2; pp. 254 - 258
Main Authors: Griffiths, Paul, Mounteney, Jane, Lopez, Dominique, Zobel, Frank, Götz, Wolfgang
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01.02.2012
Subjects:
Academies and Institutes - organization & administration
Academies and Institutes - trends
Addiction
Annual reports
Best practice
Best practices
Catalysts
Creativity
Criminal Justice Policy
Drug Abuse
Drug Addiction
Drug Information Services - organization & administration
Drug policy
Drug use
Drugs
Epidemiology
Europe
European Union
Forecasting
Founding
Health Policy
Humans
illicit drugs
Information Storage and Retrieval
Intervention
Languages
monitoring
Networks
Organizational Objectives
policy
Priorities
Regulation
Research centers
Street Drugs - legislation & jurisprudence
Substance-Related Disorders
Europe
European Union
ISSN:0965-2140, 1360-0443, 1360-0443
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug‐related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a common information framework to support the drugs debate. In order to achieve its mission, the EMCDDA coordinates and relies on a network of 30 national monitoring centres, the Reitox National Focal Points. The Centre publishes on a wide range of drug‐related topics, across epidemiology, interventions, laws and policies. Every November, the EMCDDA publishes its Annual Report, providing a yearly update on the European drug situation, translated into 23 EU languages. In line with its founding regulation, the EMCDDA has a role acting as an interface between the worlds of science and policy. While not a research centre in the formal sense, the results the Centre generates serve as catalysts for new research questions and help to identify priorities. Current challenges facing the agency include continuing to increase scientific standards while maintaining a strong institutional role, as well as supporting European efforts to identify, share and codify best practice in the drugs field.
Bibliography:istex:9C1999C9BE838445A7DC68C49561CAA70418B02D
ark:/67375/WNG-TBTTRM4K-F
ArticleID:ADD3369
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ISSN:0965-2140
1360-0443
1360-0443
DOI:10.1111/j.1360-0443.2011.03369.x